UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) May 1, 2012
NEOGEN CORPORATION
(Exact name of registrant as specified in its charter)
MICHIGAN | 0-17988 | 38-2367843 | ||
(State or other jurisdiction Of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
620 Lesher Place Lansing, Michigan | 48912 | |||
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code 517-372-9200
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.01. Completion of Acquisition or Disposition of Assets
On May 1, 2012 Neogen Corporation issued a press release announcing that it had acquired the assets of the Igenity animal genomics business from Merial Limited. Igenity had been a significant customer of Neogens Geneseek business unit.
Neogen intends to move the business to its Geneseek unit in Lincoln, Nebraska, which reports within Neogens Animal Safety segment.
A copy of the press release is attached as Exhibit 99.1 to this report.
ITEM 9.01. | Financial Statement and Exhibits |
(a) Financial statements and pro forma financial statements of the business acquired are inapplicable and, therefore, have been omitted.
(b) Exhibit 99.1Press Release dated May 1, 2012 announcing Neogen Corporations acquisition of the assets of the Igenity animal genomics business from Merial.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NEOGEN CORPORATION (Registrant) | ||||||
Date: May 1, 2012 |
/s/ Steven J. Quinlan | |||||
Steven J. Quinlan Vice President & CFO |